Linda Elsegood

Founder and Trustee at LDN (Low Dose Naltrexone) Research Trust.

Follow Linda on Social
Profile picture of linda-elsegood

Linda Elsegood is the founder and trustee of LDN (Low Dose Naltrexone) Research Trust, an organization she started in 2009 to support research on Low Dose Naltrexone (LDN).

Linda was diagnosed with Multiple Sclerosis in 1985, and her journey to find effective treatments for her condition led her to discover LDN. She was amazed at the results of taking the drug, which prompted her to begin researching its potential for treating other conditions, such as chronic pain and autoimmune diseases.

Since then, Linda has dedicated her life to advocating for the use of LDN and helping raise awareness about its benefits. She has traveled around the world to speak at conferences, participate in panels, and give lectures on LDN’s potential medical applications.

In 2009 she founded LDN Research Trust, a charity to promote clinical trials and research into the positive effects of taking Low Dose Naltrexone (LDN).

To date, Linda has raised over £2 million to fund a number of successful studies. She also works closely with scientists and clinicians all over the world to ensure that LDN.

Podcast hosted by Linda Elsegood

Books written by Linda Elsegood

Topics discussed by Linda Elsegood

All Linda Elsegood's Topics

Topics discussed by Linda Elsegood in books and podcast appearances.